Objective: Identification of novel regulators involved in adipose development is important to understand the molecular mechanism underlying obesity and associated metabolic disorders. Through isolation and analysis of a vitamin K epoxide reductase Vkorc1l1 mutant, this study aimed to disclose its function and underlying mechanism in adipose development and to obtain valuable insights regarding the mechanism of obesity. Methods: A Vkorc1l1 mutation recovered from a forward genetic screen for obesity-related loci in mice was characterized to explore its effects in gene expression, animal metabolism, and adipose development. Adipogenesis was evaluated in both Vkorc1l1 mutant stromal vascular fraction and Vkorc1l1 knockdown preadipocytes. Intracellular vitamin K 2 level and the effect of vitamin K 2 on adipogenesis were tested in primary preadipocytes. Results: Vkorc1l1 mutants displayed a considerably lower fat to body weight ratio, substantially decreased plasma leptin, and significantly underdeveloped white adipose tissue. Adipogenic defects related with Vkorc1l1 deficiency were observed both in vivo and in vitro. Vitamin K 2 could inhibit adipogenesis in stromal vascular fraction. Increased intracellular vitamin K 2 level was detected in Vkorc1l1 mutant preadipocytes. Conclusions: Vkorc1l1 promotes adipogenesis and possibly obesity. Downregulation of Vkorc1l1 increases intracellular vitamin K 2 level and impedes preadipocyte differentiation.
Introduction
The accumulation of extra adipose tissue is one of the most characteristic features of obesity. It occurs through both enlargement of adipocyte size (hypertrophy) and increase of adipocyte number (hyperplasia) (1) . In mammals, the brown adipose tissue (BAT) and white adipose tissue (WAT) are the two major types of adipose tissue. BAT is the site for thermogenesis and energy expenditure, while WAT is the major site for energy storage. Extensive cold exposure may stimulate the expression of UCP1 and other thermogenic genes in some WAT cells, which converts these cells to the beige adipocytes (2) . In mice, BAT development initiates around embryonic days 15 and 16 (E15-E16) (3), while WAT develops later. The development of subcutaneous WAT starts around E17.5 to E18.5, followed by rapid lipid accumulation in adipocytes after birth (4) . Perigonadal WAT (pgWAT) develops after birth and starts accumulating lipid at the age of day 7 (P7) (5) . The adipogenic process also takes place in the adult stage. In particular, high-fat diet (HFD)-induced adipogenesis has been well characterized by lineagetracing experiments in adult mice (6) . Approximately 5% of adipocytes are replaced daily in adult mice (7) . In adult humans, the turnover rate is approximately 10% per year (8) .
White adipocytes are differentiated from preadipocytes in a process known as adipogenesis. Most preadipocytes are originated from cells residing in adipose stromal vascular regions (9, 10) . During adipogenesis, they undergo morphological and functional change from spindle-shaped fibroblast-like cells into round and lipid-laden adipocytes (11) . Bone-marrow-derived cells (BMDCs) serve as another source of adipocytes (12, 13) . However, the contribution of the hematopoietic lineage to the whole preadipocyte pool is fairly low and also displays a gender-specific pattern. The contribution of BMDCs in females is fourfold that in males (13) .
Vitamin K is a group of fat-soluble vitamins that includes the following two natural vitamers: vitamin K 1 and vitamin K 2 . Vitamin K 1 exists primarily in green leafy vegetables and can be converted to menaquinone-4, a major form of vitamin K 2 , in mammal tissues (14, 15) . Vitamin Ks are well known for their roles in blood coagulation and bone health because of their functions in carboxylating certain glutamate residues in coagulation factors and bone proteins (14) . Vitamin K deficiency caused by intestinal injury or genetic disorders may lead to severe bleeding and death (16, 17) . In anticoagulated patients, genetic polymorphisms related to vitamin K homeostasis are associated with hemorrhagic risks (18) . Although vitamin K 1 and K 2 share similar structures and are generally considered to have similar physiological functions, experimental evidence has also suggested the functional specificities associated with each. For example, the phosphorylation of protein kinase A (PKA) could be induced by vitamin K 2 but not vitamin K 1 (19) . Similarly, only vitamin K 2 could bind to the steroid and xenobiotic receptor (20) .
Vitamin K homeostasis is maintained by the vitamin K recycling that converts vitamin K epoxide to vitamin K and further to vitamin K hydroquinone (21) . These processes could be catalyzed by both vitamin K epoxide reductase complex subunit 1 (Vkorc1) and its paralogue vitamin K epoxide reductase complex subunit 1 like 1 (Vkorc1l1). Vkorc1 is apparently more effective in the first step, while Vkorc1l1 works more efficiently for the second (22) . As expected, disruption of Vkorc1 resulted in severe bleeding and premature death in mice (17) . On the other hand, the in vivo role of Vkorc1l1 remains to be understood.
We have identified a Vkorc1l1 mutant through a forward genetic screen for obesity-related loci in mice (23) . In this report, we show that disruption of Vkorc1l1 leads to defective adipogenesis associated with increased vitamin K 2 in preadipocytes. These results not only revealed a significant physiological function of Vkorc1l1 but also expanded our knowledge regarding the initiation and progression of obesity.
Methods Animals
All animal experiments were performed in accordance with guidelines from the Institutional Animal Care and Use Committee of the Institute of Developmental Biology and Molecular Medicine. Wild-type and mutant FVB/NJ mice were maintained in a specific pathogen-free facility with 12/12-hour light/dark cycles on normal chow diet or HFD. The piggyBac (PB) insertion (080508020-HRA) in Vkorc1l1 was mapped in the first intron, with the PB targeted sequence TTAA at 130,446,713 bp of chromosome 5 (Ensembl version 53).
General and metabolic physiology
Mice were weighed and placed in a minispec nuclear magnetic resonance (NMR) instrument (Bruker, Billerica, Massachusetts) to measure the mass and ratio of body fat and lean compositions. Anal to nasal distance was measured as the body length. A fasting period of 8 hours was applied to 12-week-old mice prior to plasma hormone tests. Blood samples were then collected from the orbital sinus and analyzed with the Mouse Leptin and Insulin Ultrasensitive ELISA Kits (Crystal Chem, Inc., Elk Grove Village, Illinois).
For the intraperitoneal glucose tolerance test (IPGTT), 12-week-old mice were fasted for 16 hours before receiving an intraperitoneal injection of 20% glucose saline solution (2 g glucose per kilogram body weight). Tail vein blood was sampled at 0, 30, 60, and 120 minutes after injection. Area under curve of IPGTT data was calculated by Microsoft Excel (Redmond, Washington).
For triglyceride (TG) measurement, weighed adipose tissues were first homogenized in 500 lL of ddH 2 O (prepared on site by a Millipore machine; Millipore, Burlington, Massachusetts) containing 5% NP-40 (Sangon Biotech, Shanghai, China). An aliquot of 10 lL 50-fold water diluted sample was then used to measure the TG concentration with a Triglyceride Assay Kit (EnzyChrom; BioAssay Systems, Hayward, California), such that the total amount of TG in adipose tissue could be calculated.
To determine the bone density, femurs were scanned by an Inveon CT (Siemens, Munich, Germany) and analyzed by the Inveon Research Workplace software.
Histology
Adipose tissues were fixed in ethanol and embedded in paraffin as described (24) . Samples were sectioned at 10 lm and stained with hematoxylin and eosin.
Liver samples and subcutaneous adipose tissue of newborn mice were fixed in 4% paraformaldehyde, dehydrated in 30% sucrose at 48C, prepared for 8-lm sections, and stained with hematoxylin and eosin as described (23) .
Determination of adipocyte size and number
Individual adipocytes were isolated from adipose tissue by type I collagenase (Sangon Biotech) digestion as described (25) . Adipocyte volumes were calculated with cell diameters measured by an EVOS XL Core Cell Imaging System (Thermo Fisher Scientific, Waltham, Massachusetts) and the NIH ImageJ software (Bethesda, Maryland) according to previous reports (26, 27) . The average adipocyte volume was calculated based on the data collected from three mice for each genotype, with approximately 200 adipocytes observed in each mouse.
Cell culture
Primary preadipocytes (stromal vascular fraction [SVF] cells) were isolated from inguinal WAT (iWAT) or interscapular BAT of P10 mice with type I collagenase (Sangon) as described (25) . SVF cells and 3T3-L1 cells were cultured in DMEM/F12 medium containing 10% fetal bovine serum (FBS) (HyClone, GE Healthcare, Chicago, Illinois), 1% penicillin-streptomycin (Gibco, Gaithersburg, Maryland), and 1% L-glutamine (Gibco). SVF cells were differentiated by adding 10-lg/mL insulin (Sigma-Aldrich, St. Louis, Missouri), 1nM 3,3',5-triiodo-L-thyronine (T3; Sigma-Aldrich), and 125mM indomethacin (Sigma-Aldrich) for 8 days. 3T3-L1 cells were treated Obesity Vkorc1l1 Promotes Adipogenesis in Mice Ding et al.
for differentiation by 5-lg/mL insulin (Sigma-Aldrich), 250nM dexamethasone (Sigma-Aldrich), and 0.5mM IBMX (Sigma-Aldrich) on the first 2 days and by 5-lg/mL insulin for another 4 days. The differentiation medium was changed once every 2 days.
Vkorc1l1 small interfering RNA (siRNA) (5 0 -CCU CAG AAU CUU AAA CUG AUU TT-3 0 , GenePharma, Shanghai, China) and scramble siRNA (5 0 -UUC UCC GAA CGU GUC ACG UTT-3 0 , GenePharma) were transfected by Lipofectamin RNAiMax (Life Technologies, Carlsbad, California) according to the manufacturer's protocol. To test the knock efficiency, Western blot was performed 6 days after the transfection as previously described (28) .
Lipolysis and lipogenesis analysis
To measure the basal level of lipolysis, four pieces of 50-mg perigonadal adipose tissue isolated from 6-hour-fasted mice were incubated at 378C in 1 mL of OPTI-MEM (Gibco) containing 2% fatty-acid-free bovine serum albumin (BSA) for 2 hours. An aliquot of 10 lL medium was then used to measure the glycerol level with a Free Glycerol Assay Kit (Abcam, Cambridge, UK). To measure the stimulated level of lipolysis, 10lM Forskolin (Beyotime, Shanghai, China) was added in the OPTI-MEM fatty-acid-free BSA system for incubation.
For the quantification of lipogenesis, in vitro differentiated iWAT SVFs were cultured in OPTI-MEM containing 10% FBS with or without 25mM glucose for 2 days. Cells were homogenized in 1 mL of ddH 2 O containing 5% NP-40. The TG content was measured in 10 lL fivefold water diluted sample by a Triglyceride Assay Kit (EnzyChrom).
Fluorescence activated cell sorting counting of primary preadipocytes
Isolated SVF cells were resuspended in ice-cold phosphate-buffered saline (PBS) with 5% FBS and stained with antimouse CD31 PECyanine7 (catalog 25-0311; 1:100; eBioscience; Thermo Fisher Scientific, Waltham, Massachusetts), antimouse CD45 Alexa Fluor 700 (catalog 56-0451; 1:100; eBioscience), antimouse TER-119 APCeFluor 780 (catalog 47-5921; 1:100; eBioscience), antimouse/rat CD29 APC (catalog 17-0291; 1:100; eBioscience), antimouse CD34 eFluor 450 (catalog 48-0341; 1:50; eBioscience), and antimouse Sca-1 FITC (catalog 11-5981; 1:100; eBioscience). Labeled samples were analyzed by Gallios flow cytometer (Beckman Coulter, Indianapolis, Indiana) and FlowJo software (FlowJo, LLC, Ashland, Oregon).
Oil Red O staining
Differentiated SVF or 3T3-L1 preadipocytes were fixed by 10% formalin at room temperature for 1 hour, incubated in 0.5% Oil Red O solution (dissolved in 60% isopropanol and 40% distilled water and filtered before use) for 30 minutes at 378C, and extensively washed by distilled water before visualization. For quantitive experiments, Oil Red O was eluted by isopropanol and measured spectrophotometrically at 490 nm.
For differentiation experiments with vitamin K 1 or K 2 , SVF cells were incubated with vitamin K 1 or K 2 throughout adipogenic induction and before Oil Red O staining. Relative differentiation rate was calculated by the ratio of quantified Oil Red O at 490 nm for each group treated with a different concentration of vitamin K 1 or K 2 to the solvent-treated group, which was set as 100%.
Frozen liver sections (8 lm) were fixed by 10% formalin at room temperature for 10 minutes, followed by a brief wash in 60% isopropanol aqueous solution. The samples were then stained in 0.5% Oil Red O solution followed by a brief wash in 60% isopropanol aqueous solution. Finally, the samples were briefly stained in hematoxylin solution and mounted with 80% glycerol aqueous solution.
Generation of Vkorc1l1 antibody
The Vkorc1l1 antibody was generated by ABclonal Biotechnology Co., Ltd (Woburn, Massachusetts). The antigen peptide is LVYL-NEAWKRQLQPKED (amino acids 160-176 in the C-terminus). The antibody was produced by immunizing rats and affinity purified with the antigen.
Reverse transcription-polymerase chain reaction and Western blot
Total RNA was extracted with TRIzol (Invitrogen Corp., Carlsbad, California) and reverse transcribed (Takara Bio, Mountain View, California). Quantitative polymerase chain reaction (PCR) was performed using Brilliant QPCR Master Mix (Agilent Technologies, Santa Clara, California). 18s ribosomal RNA was used as an internal control.
Total protein was extracted from cultured cells with ice-cold radioimmunoprecipitation assay buffer and centrifuged at 15,000g. The supernatant was resolved by 10% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE), electrophoresis electrotransferred to a polyvinylidene difluoride membrane, and probed with rat anti-VKORC1L1 (1:200; generated by ABclonal), mouse anti-b-actin (catalog ab008-100; 1:2,000; Multisciences, Zhejiang, China), goat anti-rat IgG-HRP (catalog sc2006; 1:2,000; Santa Cruz Biotechnology, Dallas, Texas), or goat anti-mouse IgG-HRP (catalog sc2005, 1:2,000; Santa Cruz Biotechnology) antibodies. Densitometric quantification of VKORC1L1 protein level was determined by ImageJ and compared with b-actin (internal control) to determine the relative expression level.
Intracellular vitamin K 2 determination
Confluent SVF cells were treated with 16lM vitamin K 2 (menaquinone-4, Sigma-Aldrich) overnight. Cells were harvested, frozen, and thawed repeatedly by prechilled ethanol in liquid nitrogen and then sonicated. Cell lysates were dried in vacuo, dissolved in methanol, and resolved by high-performance liquid chromatography (HPLC) (Agilent SB-C18 column, 50*2.1 mm, 1.8 lm), with a mobile phase comprising methanol and isopropanol (50:50, v/v) at 0.4 mL/min. Vitamin K 2 signal peak was identified by comparing signals of wild-type SVF cells treated with 16lM vitamin K 2 with those of nontreated cells.
Statistics
Unless stated, data were presented as the mean 6 SEM. An unpaired two-tailed Student t test was used to determine statistical significance.
Results

Disruption of Vkorc1l1 causes lean phenotype in mice
The Vkorc1l1 mutant was identified through a large-scale insertional mutagenesis project with the PB transposon (23 PB transposon was inserted in the first intron, which caused severely reduced gene expression ( Figure 1A ). In pgWAT, Vkorc1l1 mRNA was decreased by approximately 50% in heterozygous (Vkorc1l1 PB/1 ) mice and essentially eliminated in the homozygotes (Vkorc1l1 PB/PB ) ( Figure 1B) . In iWAT, VKORC1L1 proteins were undetectable in the homozygotes ( Figure 1C ). Severe reduction of Vkorc1l1 mRNA was also detected in the BAT of Vkorc1l1 PB/PB mice (Supporting Information Figure S1A ). In contrast, mRNA levels of Vkorc1, the paralogue of Vkorc1l1, were not affected in mutant WAT or BAT (Supporting Information Figure S1B ).
Vkorc1l1
PB/PB animals are viable at birth (Supporting Information Figure S1C ). They survive to adulthood with no obvious hemorrhage or other life-threatening abnormalities. However, homozygous mutants are apparently smaller than their wild-type littermates ( Figure 1D ), which may contribute to the smaller litter size of homozygous parents (Supporting Information Figure S1D ). The average body length of Vkorc1l1 PB/PB mice was approximately 10% less than that of the agematched wild-type animals ( Figure 1E ). In addition, the average body weight of female and male Vkorc1l1 PB/PB mice were 20.0% and 18.6% less than those of the wild-type littermates, respectively ( Figure 1F ). Figure S1E ).
Meanwhile, the bone density of homozygous mutants was not affected (Supporting Information
To determine whether the lower body weight of Vkorc1l1 PB/PB mice resulted from less body fat, we measured their body compositions with NMR. Compared with those of the wild-type littermates, both fat and lean masses were reduced in Vkorc1l1 PB/PB mice ( Figure  1G-1H ). In addition, the fat to body weight ratio was decreased by approximately 30% and 40% in female and male mutants, respectively ( Figure 1I ). Enzyme-linked immunosorbent assay (ELISA) analysis also revealed a significant decrease of plasma leptin levels in homozygous mutants ( Figure 1J ). These results confirmed loss of body fat in Vkorc1l1 PB/PB animals. Lipodystrophy is a rare genetic disorder characterized by loss of subcutaneous adipose tissue, which is often associated with insulin resistance, diabetes, and hepatic steatosis. Lipodystrophy has also been observed in Agpat2 and Seipin mutant mice (29, 30) . To test whether this condition exists in Vkorc1l1 mutants, we examined insulin sensitivity of Vkorc1l1 PB/PB mice. When raised with normal chow diets, 12-week-old mutants and their wild-type littermates behaved comparably in the IPGTT (Figure 2A-2C) . Their plasma insulin levels and hepatic fat accumulation conditions were also similar ( Figure 2D-2E ). When fed with HFD for 8 weeks, female mutants performed even better in IPGTT (Supporting Information Figure S1F ). These results suggested that lipodysdrophy does not exist in Vkorc1l1 PB/PB mice by this age.
To verify that the PB insertion was the causative mutation of these phenotypes, we crossed Vkorc1l1 PB/PB animals with mice expressing the PB transposase to generate genetic revertants (Vkorc1l1 rev/rev ) (23). Precise excision of the PB transposon in Vkorc1l1 rev/rev mice was verified by sequencing (Supporting Information Figure S2A ). In the revertants, Vkorc1l1 transcription was recovered (Supporting Information Figure S2B ). Mutant phenotypes such as alterations of the body weight, body length, and adipose tissue weight were no longer observed (Supporting Information Figure S2C-S2H ). Taken together, these results indicated that disruption of Vkorc1l1 led to the lean phenotype in mice.
Vkorc1l1 mutation affects white but not brown adipose
Both WAT and BAT may be affected in Vkorc1l1 PB/PB mice to contribute to the observed lean phenotypes. To explore these possibilities, we examined iWAT, pgWAT, and retroperitoneal WAT (rWAT) as well as the interscapular BAT in 6-week-old Vkorc1l1 PB/PB mice. Compared with those of the wild-type littermates, all mutant WATs exhibited smaller sizes ( Figure 3A) , lower weights, and lower tissue to body weight ratios ( Figure 3B-3E) . In fact, mutant WATs weighed only approximately half of the wild-type WATs. Detailed analysis of the pgWAT showed that compared with the wild-type adipose tissues, Vkorc1l1 PB/PB adipose tissues had 27.8% fewer adipocytes in total ( Figure 3F ) and 18.2% less TG per gram of weight ( Figure 3G ). At the same time, the mutant adipocytes were 30.4% smaller than wild-type adipocytes ( Figure 3H-3I) . In contrast, the size of BAT and the BAT to body weight ratio of mutant mice were comparable with those of the wild-type littermates, although the weight of female BAT was 20.7% lighter ( Figure 3A-3E) . These results indicated that WATs were the major adipose depots affected by Vkorc1l1 mutations in mice.
Vkorc1l1 mutation impairs preadipocyte differentiation
Induced beiging of WAT could stimulate the expression of thermogenic genes, which may in turn result in the lean phenotype (31) . This is unlikely the case of Vkorc1l1 PB/PB mutants because quantitative reverse transcription-polymerase chain reaction (RT-PCR) detected approximately 50% decreased expression of thermogenic genes Ucp1 and Pgc1a in the iWAT of P10 homozygotes (Supporting Information Figure S3A ). Defects in lipolysis and lipogenesis could also contribute to the lean phenotype in mice (32, 33) . However, no significant mRNA level alterations were observed for genes involved in lipolysis or lipogenesis upon the disruption of Vkorc1l1 (Supporting Information Figure S3B-S3D) . Consistent with this observation, we did not detect significant changes of glycerol release or TG accumulation in mutant tissues (Supporting Information Figure S3C -S3E). We thus followed adipose development, as smaller WATs in Vkorc1l1 PB/PB mice could also be explained with defective tissue development. Examining mutant animals at birth, we found that the body weight of Vkorc1l1 PB/PB mice was significantly decreased by 11.8% (Supporting Information Figure S3F ). Necropsy analysis did not reveal gross malformations or weight alterations of organs such as BAT, liver, heart, or lung (Supporting Information Figure S3G ), but it revealed a thinner cervical subcutaneous fat layer in newborn Vkorc1l1 PB/PB mice ( Figure 4A ). NMR analysis also detected significantly reduced fat to body weight ratios in Vkorc1l1 PB/PB mice at the age of 13 days (Supporting Information Figure S3H ). These results strongly suggested defects in adipogenesis in Vkorc1l1 PB/PB mice.
Adipogenic defects could result either from loss of preadipocytes (34) or from defective preadipocyte differentiation (35) . We tested the former possibility by examining the expression of preadipocyte genes in adipose-derived regenerative and stem cells, which were defined collectively as the SVF (36) . Quantitative RT-PCR detected increased expression of Pdgfra, Pdgfrb, and NG2 in iWAT-derived SVF from 6-week-old Vkorc1l1 PB/PB mice. Upregulation of Pdgfra, Pdgfrb, and Vcam1 was also recognized in pgWAT-derived SVF from mutants at the same age. No decreased expression was observed for any of these preadipocyte genes ( Figure 4B and Supporting Information Figure S3I ). The number of preadipocytes (Ter119-:CD31-:CD45-:CD341:CD291:Sca11) was increased by sixfold in iWAT-derived SVF from mutants ( Figure 4C and Supporting Information Figure S4 ), as determined by flow cytometry. Thus, the decrease of preadipocyte population is unlikely the reason for adipogenic defects in Vkorc1l1 PB/PB mice.
We then examined the differentiation of preadipocytes by measuring the expression of mature adipocyte genes, such as Pparg2, Ap2, adiponectin, and adipsin. Quantitative RT-PCR analysis of iWAT samples detected approximately 50% downregulation of these genes in Vkorc1l1 PB/PB mice compared with those in wild-type littermates at the age of 10 days ( Figure 4D ). Induced differentiation of iWATderived SVF at the same age also resulted in aberrant differentiation. Absolute weight and fat to body weight ratios of pgWAT, rWAT, iWAT, and BAT depots from 6-week-old mice (n 5 56 for each group). (F) Adipocyte number of pgWAT depots from 6-week-old mice (n 5 3 for each group). (G) TG content in pgWAT depots from 6-week-old mice (n 5 3 for each group). (H) Representative hematoxylin and eosin stainings of pgWAT and (I) quantification of adipocyte size in 6-week-old mice (n 5 3 for each group). Scale bar, 50 lm. Data were presented as mean 6 SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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After in vitro induction, Oil Red O staining detected a decreased number of lipid droplets with smaller sizes in Vkorc1l1 PB/PB than in wild-type SVF cultures ( Figure 4E-4F) . Transcription of mature adipocyte genes was also significantly decreased ( Figure 4G ). Similar adipogenic defects could be observed in 3T3-L1 preadipocytes when Vkorc1l1 expression was knocked down (Supporting Information Figure S3J -S3K). These results indicated that Vkorc1l1 mutations led to defective preadipocyte differentiation.
Vitamin K 2 impairs adipogenesis and accumulates in Vkorc1l1-deficient preadipocytes
Previous studies have shown that induced adipogenesis in bone marrow cells could be inhibited by vitamin K 2 but not by vitamin K 1 (12) . Considering the vitamin K epoxide reductase activity of Vkorc1l1 (22), we hypothesized that defective preadipocyte differentiation caused by Vkorc1l1 mutations may be contributed by vitamin Representative cell morphology and (G) relative mRNA expression of mature adipocyte marker genes of differentiated iWAT SVF from P10 mice (n 5 6 for each group). Scale bar, 50 lm. Data were presented as mean 6 SEM. *P < 0.05; **P < 0.01; ***P < 0.001. K 2 accumulation. To test this hypothesis, we first examined whether vitamin K 2 treatment could block preadipocyte differentiation. By incubating wild-type SVF cells with 16lM vitamin K 2 during adipogenic induction, we detected fewer adipocytes with Oil Red O staining and decreased expression of Pparg2 ( Figure 5A and Supporting Information Figure S5A ). Quantitative comparison of OD490 value of the staining results further revealed that SVF cell differentiation was inhibited by vitamin K 2 in a dosage-dependent manner ( Figure 5B ). In contrast, vitamin K 1 did not affect SVF cell differentiation (Supporting Information Figure S5B ). To further analyze whether the Vkorc1l1 mutation induces vitamin K 2 accumulation, we examined intracellular vitamin K 2 levels by HPLC. We found Vkorc1l1 PB/PB iWAT-derived SVF cells had 34.4% more vitamin K 2 than wild-type SVF cells ( Figure 5C ), indicating that vitamin K 2 metabolism was diminished by Vkorc1l1 mutations. Intracellular vitamin K 2 was also increased in mutant BAT-derived SVF cells but to a lesser extent. Compared with wild-type BAT-derived SVF cells, Vkorc1l1 PB/PB cells had 15.1% more vitamin K 2 (Supporting Information Figure S5C ).
Discussion
In this study, we have reported a previously unknown function of Vkorc1l1 in adipogenesis. This was supported by the fact that Vkorc1l1 mutation led to underdeveloped WAT at birth and defective adipogenesis in cultured preadipocytes. Because of the increased number of preadipocytes and decreased adipocyte size in Vkorc1l1 mutants, the observed adipogenic defects were not likely because of the loss of preadipocyte pool but more possibly caused by the accumulation of undifferentiated preadipocytes. BMDCs could also differentiate into adipocytes with a gender-specific pattern. However, considering that mutants of both genders showed severe defects in adipose tissues, it is unlikely that the defects of hematopoietic lineage cells were the main causes of the phenotypes of Vkorc1l1 PB/PB mice.
Despite the severe WAT defects, lipodystrophic phenotypes such as insulin resistance, diabetes, and hepatic steatosis were not found in Vkorc1l1 PB/PB mice. This could be due to the fact that WATs were not totally disrupted, such that the function of lipid storage partially remained in adipocytes to prevent ectopic fat deposition. Alternatively, the lipodystrophic phenotypes might occur in a later stage in the mutant life.
A previous report showed that vitamin K 1 could not inhibit the differentiation of preadipocytes in vitro (37) . In our study, we have shown that vitamin K 2 but not vitamin K 1 suppressed adipogenesis of SVF cells. Consistent with our data, rats fed with either extra vitamin K 1 or K 2 displayed decreased body fat and serum TG (38) . Considering that local tissues are likely capable of converting vitamin K 1 to vitamin K 2 in animals (15), these results support that vitamin K 2 plays the major role in impeding adipogenesis in mammals (14,37). As we have shown, vitamin K 2 could suppress the expression of Pparg2, which is a key regulator in promoting adipogenesis (Supporting Information Figure  S5A ). This could explain how vitamin K 2 suppresses adipogenesis. In addition, vitamin K 2 may regulate adipogenesis through PKA. It has been reported that vitamin K 2 could stimulate PKA, while hyperactive PKA could, in turn, suppress adipogenesis (19, 39) .
Although the organ weight of newborn pups and the bone density of adult mice were not affected by Vkorc1l1 deficiency, reduced lean mass and body length were observed. These phenotypes suggested that vitamin K 2 accumulation may affect tissues in addition to WAT. Vitamin K 2 treatment could induce apoptosis in several cell lines (40, 41) . A similar process may contribute to the growth defects in Vkorc1l1 PB/PB mice. An overdose of vitamin K 1 may have similar effects, as it could be converted to vitamin K 2 in vivo (15).
Vkorc1 knockout mice displayed severe hemorrhagic phenotypes and died prematurely, while Vkorc1l1 PB/PB mice were viable and fertile with a lean and small body (17) . These differences in phenotypes indicated a significant difference between physiological functions of Vkorc1 and Vkorc1l1, despite both possessing vitamin K epoxide reductase activity in vitro. In fact, these two paralogues appear to have significant differences in their structure and biochemical properties. Specifically, protein structure prediction suggested three transmembrane domains in Vkorc1 but four in Vkorc1l1 (22) . Fluorescence protease protection assay suggested that the N-terminus of Vkorc1 faces cytoplasm and its C-terminus faces endoplasmic reticulum lumen, while both termini of Vkorc1l1 face cytoplasm (42) . In addition, the amino acid sequence of Vkorc1 is less conserved than that of Vkorc1l1 (43, 44) . Moreover, previous data have indicated that Vkorc1, but not Vkorc1l1, is essential for vitamin-K-dependent carboxylation of osteocalcin (22, 45) . Our results have added another important function specifically associated with Vkorc1l1. The specific impact of Vkorc1l1 and vitamin K homeostasis on adipose development and their general impact on obesity and related metabolic disorders require future detailed assessment.O
